US Export Controls Backfire: USCBC Flash Survey Reveals Billions in Lost Sales and No Strategic Gain
Months long export license delays are costing US companies billions in lost exports, with 82% of pending licenses covering items already available from Chinese or international competitors — meaning the controls achie... 95% of surveyed firms cited license delays as their top challenge; 71% experienced specific dela...
Published byEdited with DeepSeek-V4-FlashImages generated with GPT Image 1.5
Months long export license delays are costing US companies billions in lost exports, with 82% of pending licenses covering items already available from Chinese or international competitors — meaning the controls achie...
95% of surveyed firms cited license delays as their top challenge; 71% experienced specific delays, and 66% have had licenses pending beyond the statutory 90 day limit.
The USCBC concluded that the regime is 'poorly calibrated,' handicapping American innovators without meaningfully advancing national security.
What does a July 2026 USCBC flash survey of 31 American companies in the technology, industrial, energy, and healthcare sectors reveal aboutA USCBC flash survey of 31 US companies finds that export-license delays are costing billions, with most controlled items already available from non-US competitors.
AI Prompt
Create a landscape editorial hero image for this Studio Global article: What does a July 2026 USCBC flash survey of 31 American companies in the technology, industrial, energy, and healthcare sectors reveal about. Article summary: Here are the key findings from the USCBC July 2026 flash survey of 31 American companies across the technology, industrial, energy, and healthcare sectors [7].. Topic tags: general, general web, user generated. Style: premium digital editorial illustration, source-backed research mood, clean composition, high detail, modern web publication hero. Use reference image context only for broad subject, composition, and topical grounding; do not copy the exact image. Avoid: logos, brand marks, copyrighted characters, real person likenesses, fake screenshots, UI text, readable text, watermarks, charts with fake numbers, clickbait thumbnails, icons, and tiny thumbnail l
openai.com
A flash survey conducted by the US-China Business Council (USCBC) in July 2026 paints a stark picture of the Trump administration's export-control licensing regime: months-long delays are costing US companies billions of dollars in lost exports, eroding American market share globally, and achieving little-to-no strategic benefit . The survey captured responses from 31 companies primarily in the technology, industrial and manufacturing, energy, and healthcare sectors .
Studio Global AI
Continue your research
This page includes a source-backed answer you can continue inside Studio Global.
What is the short answer to "US Export Controls Backfire: USCBC Flash Survey Reveals Billions in Lost Sales and No Strategic Gain"?
Months long export license delays are costing US companies billions in lost exports, with 82% of pending licenses covering items already available from Chinese or international competitors — meaning the controls achie...
What are the key points to validate first?
Months long export license delays are costing US companies billions in lost exports, with 82% of pending licenses covering items already available from Chinese or international competitors — meaning the controls achie... 95% of surveyed firms cited license delays as their top challenge; 71% experienced specific delays, and 66% have had licenses pending beyond the statutory 90 day limit.
What should I do next in practice?
The USCBC concluded that the regime is 'poorly calibrated,' handicapping American innovators without meaningfully advancing national security.
US Export Controls Backfire: USCBC Flash Survey Reveals Billions in Lost Sales and No Strategic Gain
Months long export license delays are costing US companies billions in lost exports, with 82% of pending licenses covering items already available from Chinese or international competitors — meaning the controls achie... 95% of surveyed firms cited license delays as their top challenge; 71% experienced specific dela...
Published byEdited with DeepSeek-V4-FlashImages generated with GPT Image 1.5
Months long export license delays are costing US companies billions in lost exports, with 82% of pending licenses covering items already available from Chinese or international competitors — meaning the controls achie...
95% of surveyed firms cited license delays as their top challenge; 71% experienced specific delays, and 66% have had licenses pending beyond the statutory 90 day limit.
The USCBC concluded that the regime is 'poorly calibrated,' handicapping American innovators without meaningfully advancing national security.
What does a July 2026 USCBC flash survey of 31 American companies in the technology, industrial, energy, and healthcare sectors reveal aboutA USCBC flash survey of 31 US companies finds that export-license delays are costing billions, with most controlled items already available from non-US competitors.
AI Prompt
Create a landscape editorial hero image for this Studio Global article: What does a July 2026 USCBC flash survey of 31 American companies in the technology, industrial, energy, and healthcare sectors reveal about. Article summary: Here are the key findings from the USCBC July 2026 flash survey of 31 American companies across the technology, industrial, energy, and healthcare sectors [7].. Topic tags: general, general web, user generated. Style: premium digital editorial illustration, source-backed research mood, clean composition, high detail, modern web publication hero. Use reference image context only for broad subject, composition, and topical grounding; do not copy the exact image. Avoid: logos, brand marks, copyrighted characters, real person likenesses, fake screenshots, UI text, readable text, watermarks, charts with fake numbers, clickbait thumbnails, icons, and tiny thumbnail l
openai.com
A flash survey conducted by the US-China Business Council (USCBC) in July 2026 paints a stark picture of the Trump administration's export-control licensing regime: months-long delays are costing US companies billions of dollars in lost exports, eroding American market share globally, and achieving little-to-no strategic benefit . The survey captured responses from 31 companies primarily in the technology, industrial and manufacturing, energy, and healthcare sectors .
Studio Global AI
Continue your research
This page includes a source-backed answer you can continue inside Studio Global.
What is the short answer to "US Export Controls Backfire: USCBC Flash Survey Reveals Billions in Lost Sales and No Strategic Gain"?
Months long export license delays are costing US companies billions in lost exports, with 82% of pending licenses covering items already available from Chinese or international competitors — meaning the controls achie...
What are the key points to validate first?
Months long export license delays are costing US companies billions in lost exports, with 82% of pending licenses covering items already available from Chinese or international competitors — meaning the controls achie... 95% of surveyed firms cited license delays as their top challenge; 71% experienced specific delays, and 66% have had licenses pending beyond the statutory 90 day limit.
What should I do next in practice?
The USCBC concluded that the regime is 'poorly calibrated,' handicapping American innovators without meaningfully advancing national security.
The Costs: Billions in Lost Sales and Market Share
The most frequently cited problem was the pace of license reviews. 95% of companies identified long review times as their top challenge, and 71% reported experiencing specific delays in obtaining licenses to export to China . Two-thirds of respondents (66%) have had licenses pending for at least three months, exceeding the Commerce Department's 90-day statutory requirement, while 31% reported licenses stuck in limbo for one to two years .
These delays carry a heavy price tag. More than a third (36%) of firms reported at least tens of millions of dollars in losses directly attributable to license delays, with multiple companies describing losses in the hundreds of millions or even billions . The ripple effects include:
73% lost sales to Chinese competitors
64% lost market share in China
55% lost sales to international competitors outside China
Average processing times at the Bureau of Industry and Security (BIS) have slowed markedly: 62 days in 2025, up from 38 days in 2023 .
No Strategic Gain: The Foreign Availability Problem
The survey's central finding undercuts the core justification for the controls. 82% of respondents said their pending export licenses cover items for which comparable alternatives from non-US suppliers are readily available .
Breaking that 82% down:
64% reported alternatives from both Chinese and international suppliers
9% from an international supplier only
9% from a Chinese supplier only
The implication is clear: denying a US company a license to sell a product to a Chinese customer does not prevent that customer from obtaining the same product from a competitor in China, Europe, or elsewhere. The USCBC report describes the controls as "poorly calibrated" — they weaken American companies in China, cede market share to foreign competitors, reduce profits available for R&D, and ultimately "diminish America's ability to innovate and undermine US economic security".
Procedural Breakdown: Communication and Engagement Failures
Beyond delays, companies reported serious procedural breakdowns in the licensing process:
57% cited unreliable communication from licensing officers
48% cited unclear policy interpretations
50% pointed to the lack of Technical Advisory Committee (TAC) meetings as the primary procedural challenge; BIS has curtailed most TAC engagement since 2025, removing a key channel for industry input on technical details
85% said reinstating the suspended Affiliates Rule would have a severe or moderate impact on their businesses — a rule that previously allowed certain license-free transfers among affiliated companies
Chinese Retaliation Adds Pressure
The survey also flagged risks that go beyond US policy. 27% of respondents reported retaliatory actions by the Chinese government in their sector, including withholds or delays in approvals related to rare earths .
The Bigger Picture: A Self-Inflicted Wound
The broader USCBC Member Survey 2026, which collected 175 responses, adds context: 95% of US companies still say China operations are somewhat to very important for staying globally competitive . Yet roughly half of firms affected by export controls reported lost sales to Chinese or international competitors . The USCBC's assessment is blunt — regulators are "handicapping America's most innovative companies and ceding ground to competitors without meaningfully advancing US national security".
globaltimes.cnAre US export controls really about containing China
The Costs: Billions in Lost Sales and Market Share
The most frequently cited problem was the pace of license reviews. 95% of companies identified long review times as their top challenge, and 71% reported experiencing specific delays in obtaining licenses to export to China . Two-thirds of respondents (66%) have had licenses pending for at least three months, exceeding the Commerce Department's 90-day statutory requirement, while 31% reported licenses stuck in limbo for one to two years .
These delays carry a heavy price tag. More than a third (36%) of firms reported at least tens of millions of dollars in losses directly attributable to license delays, with multiple companies describing losses in the hundreds of millions or even billions . The ripple effects include:
73% lost sales to Chinese competitors
64% lost market share in China
55% lost sales to international competitors outside China
Average processing times at the Bureau of Industry and Security (BIS) have slowed markedly: 62 days in 2025, up from 38 days in 2023 .
No Strategic Gain: The Foreign Availability Problem
The survey's central finding undercuts the core justification for the controls. 82% of respondents said their pending export licenses cover items for which comparable alternatives from non-US suppliers are readily available .
Breaking that 82% down:
64% reported alternatives from both Chinese and international suppliers
9% from an international supplier only
9% from a Chinese supplier only
The implication is clear: denying a US company a license to sell a product to a Chinese customer does not prevent that customer from obtaining the same product from a competitor in China, Europe, or elsewhere. The USCBC report describes the controls as "poorly calibrated" — they weaken American companies in China, cede market share to foreign competitors, reduce profits available for R&D, and ultimately "diminish America's ability to innovate and undermine US economic security".
Procedural Breakdown: Communication and Engagement Failures
Beyond delays, companies reported serious procedural breakdowns in the licensing process:
57% cited unreliable communication from licensing officers
48% cited unclear policy interpretations
50% pointed to the lack of Technical Advisory Committee (TAC) meetings as the primary procedural challenge; BIS has curtailed most TAC engagement since 2025, removing a key channel for industry input on technical details
85% said reinstating the suspended Affiliates Rule would have a severe or moderate impact on their businesses — a rule that previously allowed certain license-free transfers among affiliated companies
Chinese Retaliation Adds Pressure
The survey also flagged risks that go beyond US policy. 27% of respondents reported retaliatory actions by the Chinese government in their sector, including withholds or delays in approvals related to rare earths .
The Bigger Picture: A Self-Inflicted Wound
The broader USCBC Member Survey 2026, which collected 175 responses, adds context: 95% of US companies still say China operations are somewhat to very important for staying globally competitive . Yet roughly half of firms affected by export controls reported lost sales to Chinese or international competitors . The USCBC's assessment is blunt — regulators are "handicapping America's most innovative companies and ceding ground to competitors without meaningfully advancing US national security".
globaltimes.cnAre US export controls really about containing China
